INTRODUCTION
Neuropathy target esterase (NTE) is an integral membrane protein found in highest concentration in central and peripheral nerve tissue [1] [2] [3] . Inhibition of this enzyme by some organophosphate esters (OPs) and the subsequent dealkylation ('aging') of the enzymebound OP is correlated with the ability of these OPs to cause organophosphate-induced delayed neuropathy (OPIDN) [4] [5] [6] [7] [8] . This neuropathy, which appears 1-3 weeks after an acute exposure to neuropathic OPs, is characterized by muscle weakness, ataxia and paralysis of the limbs [9, 10] . Each of these symptoms is accompanied either by distal degeneration of the long large; diameter peripheral nerves or by damage to the ascending and descending tracts of the spinal cord [9] [10] [11] . There is evidence that the target site at which OP binding initiates OPIDN is pharmacologically distinct from the active site of acetylcholinesterase [12] . The role of NTE in the proper function of the nerve axon and the mechanism by which OP modification of NTE possibly initiates the delayed degeneration of the peripheral nerves has not been determined.
NTE activity is detected on the basis of its inhibition by neuropathic OPs such as di-isopropyl phosphorofluoridate (iPr2P-F) and Mipafox, and its resistance to inhibition by non-neuropathic OPs such as Paraoxon. Operationally, NTE is defined as that fraction of total phenyl valerate-hydrolysing carboxylesterase activity that is both Paraoxon-resistant and Mipafox-sensitive. To identify those Paraoxon-resistant sites that are Mipafox-sensitive, paired samples were treated with either Paraoxon, to block irrelevant iPr2P-F-binding sites, or with both Paraoxon and Mipafox. These samples were then labelled with [3H]iPr2P-F and analysed by SDS/PAGE [13, 14] . This method identified several NTE-like proteins, which in decreasing order of abundance were reported to have apparent Mr values of 160000, 82000 and 15000 [13, 14] . Williams & Johnson examined the brain regional distributions of NTE and [3H]iPr2P-F-labelled proteins and concluded that the 160000-Mr protein was distributed similarly to NTE whereas the 82000-Mr protein was not [13] . Carrington & Abou-Donia found that iPr2P-F phosphorylated each of these proteins at a rate similar to the rate at which iPr2P-F inhibits NTE [14] . These studies did not conclusively identify a specific protein as NTE, and the possibility remains that some of these proteins could be labelled in an NTE-like manner but not have any carboxylesterase activity. It is therefore important to use an analytical method that leaves the NTE activity intact, thereby allowing a direct comparison of the NTE activity and NTE-like labelled proteins.
The method described by Ishikawa et al. [15] for separating carboxylesterases on sucrose density gradients was chosen for this purpose. They reported that most of the carboxylesterase activity found in chicken brain migrated on sucrose gradients as a 4 S peak. This peak was substantially inhibited by Paraoxon, but only partially inhibited by Mipafox. A smaller peak with a 9 S sedimentation coefficient was found to have the Paraoxon-resistant Mipafox-sensitive properties of NTE. The 9 S activity had the same tissue distribution and relative activity as NTE, and it exhibited the same time course of inhibition and subsequent recovery as NTE [16] .
In the present paper the sedimentation behaviour on sucrose density gradients of both NTE [13] , and stored at -25 'C. Mipafox (NN'-diisopropylphosphorodiamidic fluoride) and phenyl valerate were synthesized as previously described [15] in accordance with the methods of Johnson [17] . The purity of Mipafox was monitored by determination of its melting point (60.5 'C, pure white crystals), and the purity of phenyl valerate was analysed by n.m.r. and i.r. spectroscopy. Paraoxon (phosphoric acid diethyl 4-nitrophenyl ester; Aldrich Chemical Co., Milwaukee, WI, U.S.A.) was analysed for interfering contaminants by t.l.c. and by determination of its I50 for NTE (600 /M) as recommended by Johnson [18] . 37 'C for 40 min [13] . Labelling was stopped by dilution of samples with 40 ml of ice-cold buffer B, followed by centrifugation as described above. Unbound [3H]iPr2P-F was removed by resuspending samples twice in 48 ml of ice-cold buffer B followed by re-centrifugation. The concentrations of protein in these samples ranged from 0.58 to 0.66 mg/ml. At the same time 16.6 mg of uninhibited unlabelled microsomal membranes was treated with 19.1 ml of the above extraction solution. These samples were centrifuged in a type 60 Ti rotor at 100000 g for 1 h at 4 'C. The soluble fractions were recovered and concentrated overnight at 4 'C against 5 litres of 1 mM-Tris/HCl buffer, pH 7.2 at 21 'C, containing 0.0250 Triton X-100, 1 mM-EDTA and 1 mM-EGTA in a Micro-ProDiCon apparatus with PA-30 dialysis membranes (30000-Mr cut-off; Bio-Molecular Dynamics, Beaverton, OR, U.S.A. [23] [24] [25] . The individual fractions from each set of four gradients were combined into four larger fractions on the basis of their profiles of phenyl valerate-hydrolysing activity and the positions of marker enzymes: fraction 1, tubes 1-8 (P, M or PM) or tubes 1-7 (C); fraction 2, tubes 9-12 (P, M or PM) or tubes 8-11 (C); fractions 3, tubes 13-17 (P, M or PM) or tubes 12-16 (C); fraction 4, tubes 18-25 (P, M or PM) or tubes 17-25 (C). These samples were prepared for electrophoresis by dialysis at 4 'C against 7 litres of 1 mM-Tris/HCl buffer, pH 7.2 at 21 'C, containing 0.0250 Triton X-100, 1 mM-EDTA and 1 mM-EGTA. Samples were then concentrated 24-64 fold to a final volume of approx. 300,u1 against 5 litres of the above buffer at 4 'C by using the Micro-ProDiCon system. SDS/PAGE of concentrated sucrose-density-gradient fractions Concentrated fractions 1, 2, 3 and 4 from each bufferor inhibitor-treated sample were subjected to SDS/ PAGE on 3 mm-thick 7.500 (w/v) polyacrylamide gels according to the Laemmli method [26] . For scintillation counting of radioactivity, sample lanes were cut into 1 mm slices. Two adjacent slices were placed in each glass scintillation vial containing 1 ml of 900 (v/v) Protosol (NEN Research Products, Boston, MA, U.S.A.) and gently shaken overnight. Then 10 ml of 27 mM-2,5-diphenyloxazole/0.22 mm-1,4-bis-(5-phenyloxazol-2-yl)benzene in toluene was added to each vial. The amount of [3H]iPr2P-F per vial was measured twice for 2 min (counting efficiency 45 %). In all cases more than 65 0 of the radioactivity loaded was recovered. Reported values are the average of these two determinatios.
For fluorography, samples were electrophoresed on 1.5mm-thick gels, and stained with Coomassie Blue R250 as indicated above. These gels were treated with En3Hance (NEN Research Products) according to the manufacturer's instructions and dried on to filter paper. Kodak X-Omat X-AR5 film (Rochester, NY, U.S.A.) was exposed to the gels at -70°C for 10 weeks before development of the film.
RESULTS
For these experiments, microsomal membranes were prepared from chick-embryo brain membranes. The yield of NTE activity in the microsomal fraction was 4700 (2.8-fold purification) and the total recovery of NTE was 980%. Fig. l(a) illustrates the profiles of total and inhibitorresistant phenyl valerate-hydrolysing activities found on a gradient loaded with an uninhibited unlabelled extract. Most of the phenyl valerate-hydrolysing activity was located in a large peak with a low sedimentation coefficient (fractions 1-11) that did not contain any NTE activity. A smaller peak of phenyl valerate-hydrolysing activity was also present that extended into the highdensity region of the gradient (fractions 12-23). NTE activity was spread fairly evenly through this region. This range of NTE activity was much broader than previously reported [15, 16] .
The sucrose density gradients containing [3H]iPr2P-Flabelled proteins were assayed to determine their distribution of [3H]iPr2P-F (Fig. lb) . The low-density peak (fractions 1-11) contained no Paraoxon-resistant Mipafox-sensitive (NTE-like) label. The high-density region (fractions 12-25) contained a broad peak of NTE-like label with a distribution that matched that of the NTE activity (Fig. la) . This supports the earlier work of Wilson et al. [16] in which the NTE activity and NTElike label from whole brain extracts were found to co-migrate on sucrose density gradients. Fractions or Paraoxon + Mipafox-treated) were combined into four fractions as described in the Materials and methods section (see Fig. 1 ). These As shown in Fig. 1 , fractions 3 and 4 both contained NTE-like labelled proteins. Analysis of fraction 3 by SDS/PAGE (Fig. 2) label at Mr 161 000 (slices 9-13), 108000 (slices [15] [16] [17] [18] and 78 000 (slices [20] [21] [22] [23] [24] (Fig. 3) contained one major band of NTElike label with an Mr of 161000 (slices 9-13) and two minor bands at Mr 116500 (slices [14] [15] [16] and 103000 (slices [16] [17] [18] [19] . The results of the Mann-Whitney test for these three regions were P < 0.005, 0.05 and 0.025 respectively. These bands were therefore found in both fractions 3 and 4 whereas the 78 000-Mr band was found only in fraction 3. The 161 000-Mr protein exhibited the strongest labelling in both fractions 3 and 4.
The SDS/PAGE profiles of fractions 1 (Table 1) . However, pretreatment with Mipafox alone almost completely inhibited the labelling of this band. This band is therefore Paraoxon-resistant and Mipafox-sensitive but is not NTE-like (Paraoxonresistant and Paraoxon + Mipafox-sensitive).
As shown in Fig. 1 , NTE was found across a much broader region of the gradients than previously reported [15] . This was probably due to aggregation of NTE during the concentration step rather than to heterogeneity or to proteolysis of NTE. The concentration step, before sucrose-density-gradient centrifugation, resulted in a 20-fold decrease in volume and a 10-fold increase in the recoverable protein concentration, while the detergent concentration only increased 4-fold. Although these conditions can be expected to lead to aggregation, the recovery of NTE activity during concentration was much greater when the increase in detergent concentration was minimized. In addition, when NTE was extracted at higher protein concentrations, which eliminated the need for a concentration step, the NTE activity was located in Table 1 . SDS/PAGE analysis of the 61 000-M, band from sucrose-density-gradient fraction 1 (see Fig. 1 a fairly distinct 9.6 S peak (Fig. 4) . Proteolysis would be expected to result in either the loss of NTE activity or a decrease in the sedimentation coefficient of NTE rather than the increase seen in these experiments.
DISCUSSION
In these experiments, microsomal membranes were prepared from chick-embryo brains, treated with neuropathic and/or non-neuropathic organophosphates, and labelled with [3H]iPr2P-F. Labelled proteins were then extracted with a high-ionic-strength Triton X-100 solution and fractionated on sucrose density gradients. [13] , and subsequently identified as a 160000-Mr protein by Carrington & Abou-Donia [14] . The 1 6 500S Mr protein appears to correspond to the 1 15 000-Mr protein previously identified in low abundance [14] . The 78000-Mr protein, which is the second most abundant NTE-like [3H]iPr2P-F-labelled protein found in hen brain microsomal membranes ( [14] ; unpublished work performed in our laboratory), was found only in fraction 3. This result is consistent with the observation by Williams & Johnson that most of the label in a region described as Band 2 (Mr 61000-125000, designated as Mr 92000) does not share the same 4-nitrophenyl di-npentylphosphinate-sensitivity and forebrain and hindbrain distribution as NTE [13] .
A 61 000Mr protein, which was resistant to Paraoxon inhibition and to Paraoxon + Mipafox inhibition, was found in fraction 1. The existence of this protein has also been confirmed in microsomal membranes isolated from hen brains (results not shown). If this protein possesses carboxylesterase activity, it would be identified by the NTE assay as an 'inhibitor-resistant esterase activity (IRE)' and not as NTE [2] . However, the labelling of this protein is almost completely inhibited by treatment criteria indicate they were a suitable tissue for this study. First, the specific activities of NTE in hen and 19-dayembryo brains were virtually identical. Secondly, highionic-strength Triton X-100 extracts of embryo brain microsomal membranes had the same profile of phenyl valerate-hydrolysing activity on sucrose density gradients as that seen previously with hen brain membranes [15] . Thirdly, with the exception of the 103 000-Mr protein, each of the NTE-like [3H]iPr2P-F-labelled proteins identified in this study have been identified in adult hen brains [14] . Finally, the method of analysis employed in these experiments is independent of the relative proportions of [3H]iPr2P-F-labelled proteins found in either adult or embryo brain. The absolute quantities of these proteins do not affect their sedimentation on sucrose density gradients or migration during SDS/PAGE.
A region of Mipafox-resistant and Paraoxon-sensitive labelling was found on the sucrose density gradients that did not correspond to a similar region of carboxylesterase activity (Fig. 3, fractions 13-15 ). This illustrates the point that Paraoxon-or Mipafox-sensitive labelling of a protein does not indicate that the protein has carboxylesterase activity. It is important, therefore, that the correlation between NTE activity and [3H]iPr2P-Flabelling also be investigated on the basis of characteristics, such as sedimentation velocity on sucrose density gradients, that are unrelated to differential inhibition by OPs. Failure to do so could lead to the inappropriate identification of a protein that does not possess carboxylesterase activity as NTE.
In summary, the results show that a 161 000Mr protein and a 116 500-Mr protein are indistinguishable from NTE on the basis of their sedimentation on sucrose density gradients. This is the first time that the correlation between NTE and a set of [3H]iPr2P-F-labelled proteins has been made by use of a method that leaves the NTE activity intact and is not solely dependent on differential inhibition by OPs. In addition, a 61 000-Mr protein was identified that is distinct from NTE, but also has the necessary characteristics to be considered a possible target site for the initiation of OPIDN. Conclusive identification of the OPIDN target site will most likely not be possible until these proteins have been purified and characterized.
